US Patent Issued to RHIZEN PHARMACEUTICALS on Sept. 30 for "Purine derivatives as SIK-3 inhibitors" (Indian, Swiss Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,422, issued on Sept. 30, was assigned to RHIZEN PHARMACEUTICALS AG (Basel, Switzerland).

"Purine derivatives as SIK-3 inhibitors" was invented by Prashant K. Bhavar (Hyderabad, India), Srikant Viswanadha (Hyderabad, India), Sridhar Veeraraghavan (Hyderabad, India), Babu Govindarajulu (Hyderabad, India) and Swaroop Kumar Venkata Satya Vakkalanka (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel inhibitors of salt-inducible kinase-3 (SIK3), methods of preparing them, pharmaceutical compositions containing them and methods for the treatment and/or prevention of kinase mediated diseases or disorde...